Understand the source comparison
Melatonin MT1/MT2 Receptor Agonism: Mechanism Comparison
Understanding how MT1 and MT2 receptors differ in signaling, localization, and functional outcome is critical for interpreting research findings and selecting appropriate agonist compounds. MT1 Gi/o → ↓cAMP, K+ channel activation, neuronal hyperpolarization SC
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how MT1 and MT2 receptors differ in signaling, localization, and functional outcome is critical for interpreting research findings and selecting appropriate agonist compounds.
- MT1
- Gi/o → ↓cAMP, K+ channel activation, neuronal hyperpolarization
- SCN, pars tuberalis, retina
- Acute inhibition of SCN neuronal firing; immediate sleep-promoting effect
- Ramelteon (6× vs melatonin)
- Reduces sleep onset latency within 30–60 min; does not shift circadian phase
- MT2
- Gi/o → ↓cAMP, CREB modulation, clock gene expression (PER/CRY)
- SCN, hippocampus, retinal ganglion cells
- Phase-shifting of circadian clock; entrainment to light-dark cycle
- Tasimelteon (balanced), UCM765 (selective)
- Adjusts timing of future sleep-wake cycles; useful for circadian misalignment (jet lag, Non-24)
- Both (Dual Agonism)
- Combined Gi/o inhibition + circadian gene regulation
- Overlapping SCN, peripheral tissues (liver, pancreas, immune cells)
- Synchronized sleep initiation + circadian realignment
- Endogenous melatonin, agomelatine
- Most physiological approach; addresses both acute insomnia and underlying circadian disruption